View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 14, 2020

Covid-19: Pittsburgh University work on vaccine; Vaxil finds candidate

The University of Pittsburgh, US, has begun efforts to develop a vaccine against the Covid-19 disease caused by the new severe acute respiratory syndrome coronavirus (SARS-CoV-2).


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Free Whitepaper
img

What is the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry?

While wanting to protect the country from being overwhelmed by Omicron, China’s adherence to a Zero-COVID policy is resulting in a significant economic downturn. COVID outbreaks in Shanghai, Beijing and many other Chinese cities will impact 2022’s economic growth as consumers and businesses experience rolling lockdowns, leading to a slowdown in domestic and international supply chains. China’s Zero-COVID policy is having a demonstrable impact on consumer-facing industries. Access GlobalData’s new whitepaper, China in 2022: the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry, to examine the current situation in Shanghai and other cities in China, to better understand the worst-affected industry sectors, foodservice in particular, and to explore potential growth opportunities as China recovers. The white paper covers:
  • Which multinational companies have been affected?
  • What is the effect of lockdowns on foodservice?
  • What is the effect of lockdowns on Chinese ports?
  • Spotlight on Shanghai: what is the situation there?
  • How have Chinese consumers reacted?
  • How might the Chinese government react?
  • What are the potential growth opportunities?
by GlobalData
Enter your details here to receive your free Whitepaper.

Follow the latest updates of the outbreak on our timeline.

The University of Pittsburgh, US, has begun efforts to develop a vaccine against the Covid-19 disease caused by the new severe acute respiratory syndrome coronavirus (SARS-CoV-2).

Currently, the university is in the process of obtaining samples of the coronavirus. The university’s Center for Vaccine Research is exploring samples of the live virus from the US Centers for Disease Control and Prevention (CDC).

The coronavirus samples will be used to create disease models to facilitate vaccine development.

University of Pittsburgh School of Medicine health sciences senior vice-chancellor Arthur Levine said: “As researchers and as an institution we have a duty to do everything we can to learn more about the novel coronavirus and develop a vaccine to help those in need. The University of Pittsburgh School of Medicine is one of the few institutions in the country equipped to work with this virus.”

The university plans to leverage its research expertise and facilities, including the Biosafety Level 3 laboratory at the Center for Vaccine Research.

Vaxil identifies Covid-19 vaccine candidate

Israeli immunotherapy biotech Vaxil Bio has announced the identification of a potential Covid-19 vaccine candidate, following in silico analyses.

The vaccine candidate is based on signal peptide technology and used the company’s VaxHit bioinformatics platform. Vaxil added that the candidate’s design builds on in-vivo testing of a tuberculosis signal peptide vaccine.

Vaxil Bio chairman and CEO David Goren said: “We have identified signal peptide combinations which we believe can be effective as a prophylactic vaccine against the current coronavirus and might also demonstrate therapeutic value in the future.”

The company intends to commence non-GMP manufacturing and testing while seeking alliances and other opportunities.

Related Companies

Free Whitepaper
img

What is the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry?

While wanting to protect the country from being overwhelmed by Omicron, China’s adherence to a Zero-COVID policy is resulting in a significant economic downturn. COVID outbreaks in Shanghai, Beijing and many other Chinese cities will impact 2022’s economic growth as consumers and businesses experience rolling lockdowns, leading to a slowdown in domestic and international supply chains. China’s Zero-COVID policy is having a demonstrable impact on consumer-facing industries. Access GlobalData’s new whitepaper, China in 2022: the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry, to examine the current situation in Shanghai and other cities in China, to better understand the worst-affected industry sectors, foodservice in particular, and to explore potential growth opportunities as China recovers. The white paper covers:
  • Which multinational companies have been affected?
  • What is the effect of lockdowns on foodservice?
  • What is the effect of lockdowns on Chinese ports?
  • Spotlight on Shanghai: what is the situation there?
  • How have Chinese consumers reacted?
  • How might the Chinese government react?
  • What are the potential growth opportunities?
by GlobalData
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology